Michael Desgagné

7PUBLICATIONS
13CO-AUTHORS
Toxicology (incl. clinical toxicology)Biologically active moleculesMedical molecular engineering of nucleic acids and proteinsBiomolecular modelling and designGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 05, 2025
Structure-Guided Optimization of Selective Covalent Reversible Peptidomimetic Inhibitors Targeting TMPRSS6.

Walid Guerrab, Matthieu Lepage, Antoine Désilets

|Aug 07, 2024
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid-Free Analgesics.

Michael Desgagné, Magali Chartier, Camille Lagard

|Jul 19, 2024
Rational In Silico Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 Subpocket.

Michael Desgagné, Antoine Désilets, Sára Ferková

|Feb 28, 2024
Insights on Structure-Passive Permeability Relationship in Pyrrole and Furan-Containing Macrocycles.

Huy M Ly, Michael Desgagné, Duc Tai Nguyen

|Jul 14, 2023
The Therapeutic Value of Solanum Steroidal (Glyco)Alkaloids: A 10-Year Comprehensive Review.

Julien A Delbrouck, Michael Desgagné, Christian Comeau

|Dec 21, 2022
Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management.

Santo Previti, Michael Desgagné, Dirk Tourwé

Pageof 2

Frequent Collaborators

6 joint publications

Pierre-Luc Boudreault

3 joint publications

Philippe Sarret

2 joint publications

Antoine Désilets

1 joint publications

Santo Previti